Takayasu arteritis is a rare, systemic, most commonly affects women of childbearing age. It is a inflammatory large-vessel vasculitis disease involving inflammation in the walls of the largest arteries in the body: the aorta and its main branches. The disease results from an attack by the body's own immune system, causing inflammation in the walls of arteries.
Takayasu arteritis is rare, but most commonly seen in Japan, South East Asia, India, and Mexico. In 1990, it was included in the list of intractable diseases maintained by the Japanese government,2 and to date 5000 patients have been registered. A study of North American patients by Hall et al found the incidence to be 2.6/million/year.6 The UK incidence is unknown.
Particularly these patients needing immunosuppressive drugs. Glucocorticoids (prednisone, prednisolone or others), often referred to as “steroids,” are an important part of treatment. The dose and length of treatment depend on how bad the disease is and how long the patient has had it. Lasting damage to arteries sometimes needs a vascular procedure or surgical treatment.